Search results for "Excipient"

showing 10 items of 80 documents

Biowaiver Monograph for Immediate-Release Solid Oral Dosage Forms: Carbamazepine.

2020

Abstract Literature relevant to assessing whether BCS-based biowaivers can be applied to immediate release (IR) solid oral dosage forms containing carbamazepine as the single active pharmaceutical ingredient are reviewed. Carbamazepine, which is used for the prophylactic therapy of epilepsy, is a non-ionizable drug that cannot be considered “highly soluble” across the range of pH values usually encountered in the upper gastrointestinal tract. Furthermore, evidence in the open literature suggests that carbamazepine is a BCS Class 2 drug. Nevertheless, the oral absolute bioavailability of carbamazepine lies between 70 and 78% and both in vivo and in vitro data support the classification of ca…

Drugmedia_common.quotation_subjectPharmaceutical ScienceAdministration OralBiological Availability02 engineering and technologyBioequivalencePharmacology030226 pharmacology & pharmacyDosage formBiopharmaceuticsExcipients03 medical and health sciences0302 clinical medicineIVIVCTherapeutic indexmedicineImmediate releasemedia_commonActive ingredientDosage Formsbusiness.industryCarbamazepine021001 nanoscience & nanotechnologyCarbamazepineSolubilityTherapeutic Equivalency0210 nano-technologybusinessmedicine.drugJournal of pharmaceutical sciences
researchProduct

Biowaiver Monographs for Immediate Release Solid Oral Dosage Forms: Cephalexin Monohydrate.

2019

Literature data and results of experimental studies relevant to the decision to allow waiver of bioequivalence studies in humans for the approval of immediate release solid oral dosage forms containing cephalexin monohydrate are presented. Solubility studies were performed in accordance with the current biowaiver guidelines of the Food and Drug Administration, World Health Organization and European Medicines Agency, taking the degradation at some pH values into consideration. Together with solubility and permeability data for cephalexin monohydrate from the literature, it was demonstrated to be a Biopharmaceutics Classification System Class 1 drug. The pharmacokinetic behavior, results of b…

Drugmedia_common.quotation_subjectPharmaceutical ScienceExcipientAdministration OralBiological Availability02 engineering and technologyBioequivalencePharmacology030226 pharmacology & pharmacyDosage formPermeabilityBiopharmaceutics03 medical and health sciences0302 clinical medicinemedicineBiopharmaceutics Classification System (BCS)HumansRegulatory scienceLADME characteristicsmedia_commonActive ingredientcephalexin monohydrateDosage FormsbioequivalenceCephalexinexcipientsbusiness.industryBiopharmaceutics021001 nanoscience & nanotechnologyBiopharmaceutics Classification SystemSolubilityTherapeutic Equivalencyregulatory science0210 nano-technologybusinessmedicine.drugJournal of pharmaceutical sciences
researchProduct

Carbon Nanodots as Functional Excipient to Develop Highly Stable and Smart PLGA Nanoparticles Useful in Cancer Theranostics

2020

Theranostic systems have attracted considerable attention for their multifunctional approach to cancer. Among these, carbon nanodots (CDs) emerged as luminescent nanomaterials due to their exceptional chemical properties, synthetic ease, biocompatibility, and for their photothermal and fluorescent properties useful in cancer photothermal therapy. However, premature renal excretion due to the small size of these particles limits their biomedical application. To overcome these limitations, here, hybrid poly(lactic-co-glycolic acid) (PLGA-CDs) nanoparticles with suitable size distribution and stability have been developed. CDs were decisive in the preparation of polymeric nanoparticles, not on…

Fluorescence-lifetime imaging microscopyphotothermal therapyBiocompatibilitylcsh:RS1-441Pharmaceutical ScienceExcipientNanoparticleNanotechnology02 engineering and technology010402 general chemistry01 natural sciencesArticleNanomaterialslcsh:Pharmacy and materia medicahybrid nanoparticleschemistry.chemical_compoundcarbon nanodotmedicinecarbon nanodotsViability assaycancer theranosticChemistryhybrid nanoparticlePLGAimagingPhotothermal therapy021001 nanoscience & nanotechnology0104 chemical sciencesPLGASettore CHIM/09 - Farmaceutico Tecnologico Applicativocancer theranostics0210 nano-technologymedicine.drugPharmaceutics
researchProduct

Comparative study of the lubricant performance of Compritol® HD5 ATO and Compritol® 888 ATO: effect of polyethylene glycol behenate on lubricant capa…

2003

The aim of this paper is to study the lubricant capacity of Compritol HD5 ATO, a glyceryl and polyethylene glycol dibehenate, obtained by atomization. This material is compared to Compritol 888 ATO, constituted only by glyceryl dibehenate. First, this study verifies that Compritol HD5 ATO and Compritol 888 ATO present the same granular characteristics and that their mixes with Lactopress present no structural differences. Secondly, in term of compressibility and cohesiveness, the use of Compritol 888 ATO or Compritol HD5 ATO with Lactopress does not involve any significant modification. Finally, the minor difference of lubricant capacity between Compritol HD5 ATO and Compritol 888 ATO has n…

GlycerolMaterials scienceCompressive StrengthChemistry PharmaceuticalPharmaceutical ScienceExcipientLactosePolyethylene glycolCompritol HD5 ATODosage formCompritol 888Polyethylene Glycolschemistry.chemical_compoundPharmaceutical technologyTensile StrengthLubricationmedicineOrganic chemistryParticle SizeLubricantGLYCERYL DIBEHENATEFatty AcidschemistryChemical engineeringMicroscopy Electron ScanningTabletsmedicine.drugInternational Journal of Pharmaceutics
researchProduct

Etenzamīda kokristāli ar karbonskābēm: saderības ar palīgvielām noteikšana

2017

Darbā noteikta etenzamīda–fumārskābes un etenzamīda–4-hidroksibenzoskābes kokristālu saderība ar dažādām palīgvielām. Kokristālu saderība ar palīgvielām tika noteikta, izmantojot diferenciālās skenējošās kalorimetrijas, pulvera rentgendifraktometrijas un Furjē transformācijas infrasarkanās spektrometrijas analīzes metodes.

KOKRISTĀLIPALĪGVIELASSADERĪBAEXCIPIENTSCOCRYSTALSĶīmija
researchProduct

Preclinical Effect of Absorption Modifying Excipients on Rat Intestinal Transport of Model Compounds and the Mucosal Barrier Marker 51Cr-EDTA

2017

There is a renewed interest from the pharmaceutical field to develop oral formulations of compounds, such as peptides, oligonucleotides, and polar drugs. However, these often suffer from insufficient absorption across the intestinal mucosal barrier. One approach to circumvent this problem is the use of absorption modifying excipient(s) (AME). This study determined the absorption enhancing effect of four AMEs (sodium dodecyl sulfate, caprate, chitosan, N-acetylcysteine) on five model compounds in a rat jejunal perfusion model. The aim was to correlate the model compound absorption to the blood-to-lumen clearance of the mucosal marker for barrier integrity, 51Cr-EDTA. Sodium dodecyl sulfate a…

KetoprofenFysiologiPhysiologyabsorption modifiersPharmaceutical ScienceExcipient51cr edtaPharmacology and Toxicology02 engineering and technologyAbsorption (skin)030226 pharmacology & pharmacyChitosan03 medical and health scienceschemistry.chemical_compound0302 clinical medicineintestinal perfusionDrug DiscoverymedicineIntestinal transportSodium dodecyl sulfatebioequivalenceChromatographypermeation enhancersPermeationFarmakologi och toxikologi021001 nanoscience & nanotechnologypharmaceutical developmentchemistryMolecular Medicine0210 nano-technologymedicine.drugMolecular Pharmaceutics
researchProduct

Influence of cryogenic grinding on properties of a self-emulsifying formulation

2003

Abstract Recently, self-emulsifying drug delivery systems (SEDDS) have been developed as a method to deliver lipophilic drugs. Gelucire® 44/14 is an excipient, from the lauroyl macrogolglycerides family, producing a fine oil-in-water emulsion when introduced into an aqueous phase under gentle agitation as SEDDS, improving thereby solubility of poorly water-soluble drugs and their bioavailability. The aims of this study were to process Gelucire® 44/14 into a powder by cryogenic grinding to produce solid oral dosage forms and to investigate influence of this process on different properties of a formulation made of Gelucire® 44/14 and ketoprofen (90/10). Cryogenic grinding produced Gelucire® 4…

KetoprofenMaterials scienceChromatographyChemistry PharmaceuticalPharmaceutical ScienceExcipientCryogenic grindingDosage formPolyethylene GlycolsDrug Delivery SystemsFreeze DryingSolubilityChemical engineeringEmulsifying AgentsEmulsionDrug deliveryMicroscopy Electron ScanningmedicineTechnology PharmaceuticalSolubilityDissolutionmedicine.drugInternational Journal of Pharmaceutics
researchProduct

Dissolution behavior of co-amorphous amino acid-indomethacin mixtures: The ability of amino acids to stabilize the supersaturated state of indomethac…

2017

Article

Magnetic Resonance SpectroscopyArgininesupersaturationIndomethacinCo-amorphousbiorelevantPharmaceutical ScienceExcipientPhenylalanine02 engineering and technologyPrecipitationprecipitation030226 pharmacology & pharmacy03 medical and health sciences0302 clinical medicineco-amorphousSpectroscopy Fourier Transform InfraredmedicineAmino AcidsSolubilityDissolutionta116Chromatography High Pressure LiquidSupersaturationChromatographyAqueous solutionCalorimetry Differential ScanningChemistryAnti-Inflammatory Agents Non-SteroidalTryptophanGeneral Medicine021001 nanoscience & nanotechnologyAmino acidSupersaturationSolubilityBiorelevant0210 nano-technologyPowder Diffractionamino acidBiotechnologymedicine.drug
researchProduct

Effects of different cellulose derivatives on drug release mechanism studied at a preformulation stage

2003

As a matter of fact, in vitro dissolution is well known to be the method of choice for the pharmaceutical industry to develop effective medicines. However, many experiments must be performed all along a new product life and they represent an overcharge of work for researchers. The purpose of this paper was to assess the relevance of new parameters obtained during preformulation stage by Nuclear Magnetic Resonance (NMR) experiments to better understand drug release mechanism. This study was carried out with three cellulose derivatives currently used as carrier matrices (Microcrystalline cellulose (MCC), Hydroxypropylmethyl cellulose (HPMC) and Ethyl cellulose (EC)). Granules and tablets were…

Magnetic Resonance SpectroscopyChemistry PharmaceuticalPharmaceutical ScienceMethylcelluloseDosage formExcipientschemistry.chemical_compoundHypromellose DerivativesTheophyllineEthyl celluloseOrganic chemistrySolubilityCelluloseCelluloseDrug CarriersNuclear magnetic resonance spectroscopyHypromellose DerivativesMicrocrystalline cellulosePharmaceutical PreparationsSolubilitychemistryChemical engineeringMicroscopy Electron ScanningPowdersDrug carrierAlgorithmsTabletsJournal of Controlled Release
researchProduct

A Hydrogel Based on a Polyaspartamide: Characterization and Evaluation of In-vivo Biocompatibility and Drug Release in the Rat

1997

Abstract This paper deals with the characterization of a new microparticulate hydrogel obtained by gamma irradiation of α,β-poly[N-(2-hydroxyethyl)-dl-aspartamide] (PHEA). When enzymatic digestion of PHEA hydrogel was evaluated using various concentrations of pepsin and α-chymotrypsin no degradation occurred within 24 h. In-vivo studies showed that this new material is biocompatible after oral administration to rats. PHEA hydrogel was also studied as a system for delivery of diflunisal, an anti-inflammatory drug. In-vitro release studies in simulated gastrointestinal juice (pH 1 or 6.8) showed that most of the drug was released at pH 6.8. In-vivo studies indicated that diflunisal-loaded PHE…

MaleBiocompatibilityAdministration OralBiological AvailabilityPharmaceutical ScienceDiflunisalExcipientPharmacologyHydrogel Polyethylene Glycol DimethacrylateDosage formPolyethylene GlycolsRats Sprague-DawleyDrug Delivery SystemsIn vivomedicineAnimalsStomach UlcerPharmacologyDrug CarriersChemistryAnti-Inflammatory Agents Non-SteroidalHydrogen-Ion ConcentrationDiflunisalMicrospheresRatsBioavailabilityGamma RaysLiberationDrug carriermedicine.drugJournal of Pharmacy and Pharmacology
researchProduct